Skip to content

A study of drug Lithium on patients of Covid 19 disease

A randomized control study to evaluate the therapeutic effects of Lithium in Covid-19 patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026193
Enrollment
100
Registered
2020-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified

Interventions

Intervention1: Group L: Tablet Lithium carbonate 600mg twice daily as add on therapy with Tablet Hydyoxychloroquine 400mg once daily with or without Azithromycin 500mg once daily for 5 days Control In

Sponsors

Maulana azad medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 70yrs 2.Positive Covid test report as per reverse transcriptase polymerase chain reaction (RT PCR) of oronasopharyngeal swabs. 3.Respiratory rate more than 30 per minute. 4.SpO2 93% or less.

Exclusion criteria

Exclusion criteria: 1.Known case of hypothyroidism 2.Renal insufficiency; Serum creatinine levels more than 1.3 mg/dl 3.Cardiac arrhythmia and cardiac disease 4.Patients on NSAID 5.Known history of QTc prolongation on ECG 6.Contraindication or allergy to hydroxychloroquine 7.Retinal eye disease 8.Pregnancy/breastfeeding

Design outcomes

Primary

MeasureTime frame
MortalityTimepoint: At week 3

Secondary

MeasureTime frame
1. Time taken for conversion to Covid negative status 2.Morbidity 3. Adverse events iii.Adverse drug monitoringTimepoint: 1.From day of report of first sample i.e.day 0, day 3, day 6 2.During stay in hospital i.e. day 3, day 6 3. During stay in hospital, day 3,day 6, day 10

Countries

India

Contacts

Public ContactDr Sumit Sural

Maulana Azad Medical College and associated Lok Nayak Hospital

sumitsural@hotmail.com9968604323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026